It was reported that to some extent, high-sensitivity AFP-L3, AFP-IgM complex, calcium, GP73, DCP bursin, VEGA, GPC-3, and other markers can improve the sensitivity for detection of tumor recurrence in AFP-negative HCC [20-23], and have predictive value for the HCC therapeutic effect [24]. Here, GPC3 is linked to hepatocellular carcinoma.